晚期卵巢癌新辅助化疗研究进展被引量：21

晚期卵巢癌新辅助化疗研究进展

原文传递

导出

摘要卵巢癌病变隐匿，具有早期扩散的生物学行为，且缺乏简便易行、特异的早期诊断方法，约70％的患者确诊时已属晚期（Ⅲ-Ⅳ期）。目前标准治疗方案是以手术为主、辅以术后化疗、放疗和生物治疗的综合方案。

作者胡欣欣张勤华齐聪

机构地区上海中医药大学附属曙光医院妇科

出处《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2011年第1期77-80,共4页 Chinese Journal of Practical Gynecology and Obstetrics

基金国家自然基金面上项目(30873280) 上海市卫生局中医药科研基金(2008X001A) 上海市科委中药现代化项目(06DZ19704)

关键词卵巢肿瘤新辅助化疗肿瘤细胞减灭术 ovarian carcinoma neoadjuvant chemotherapy optimal primary cytoreductivesurgery

分类号 R71 [医药卫生—妇产科学]

引文网络
相关文献

参考文献25

1Hegazy MA, Hegazi RA, Elshafei MA, et al. Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma [J]. World Journal of Surgical Oncology, 2005, 3( 1 ) :57-64. 被引量：1
2Bristow RE,Tomacurz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian cmvinoma during the platinum era: a meta-analysis [ J ]. Clin Oncol, 2002, 20(5) : 1248-1259. 被引量：1
3Weinberg LE,Rodriguez G,Hurteau JA, etal The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer[J]. J Surg Oncol,2010,101 (4) :334-343. 被引量：1
4Pectasides D,Farmakis D, Koumarianou A, et al. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer[ J]. Oncology, 2005,68( 1 ) :64-70. 被引量：1
5Vergote I,De Wever I, Decloedt J, et al. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian carcinoma[J]. Semin Oncol, 2000, 27(Suppl. 7) : 31-36. 被引量：1
6Steed H,Oza AM, Murphy J, et al. A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer [ J ]. Int J Gynecol Cancer, 2006, 16 ( Suppl 1 ) :47-53. 被引量：1
7Qayyum A,Coakley FV, Westphalen AC, et al. Role of CT and MR imaging in predicting optimal cytoreduetion of newly diagnosed primary epithelial ovarian cancer [ J ]. Gyneeol Oncol, 2005, 96(2) :301-306. 被引量：1
8Lee SJ,Kim BG,Lee JW, et al. Preliminary. results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery[ J ]. Obstet Gynecol Res, 2006, 32 ( 1 ) : 90-106. 被引量：1
9De laco P, Musto A,Orazi L, et al. FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy [J]. Eur J Radiot, 2010 Aug 3: [ Epub ahead of print]. 被引量：1
10Risum S, Hogdall C, Loft A, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study[J]. Gyneeol Oncol, 2008, 108(2) :265-270. 被引量：1